Pilot study on the introduction of standardized, pre-therapeutic endoscopy, possibly with marker implantation (BioXmark), in patients with esophageal cancer and primary curative therapy intention at the NCT/UCC.
Not Applicable
Recruiting
- Conditions
- C15.9Oesophagus, unspecified
- Registration Number
- DRKS00025428
- Lead Sponsor
- niversitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Strahlentherapie und Radioonkologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
histologically confirmed tumor
- Patients with cT2 N0 M0 tumors suitable for primary resection
- Patients with cT2-4 N+ M0 tumors suitable for neoadjuvant radiochemotherapy (40-41.4 Gy) followed by resection
- Patients with cT2-4 N+ M0 tumors who are eligible for primary definitive radiochemotherapy due to co-morbidities or patient preference
- Complete stenosis of the esophagus has been excluded.
- Written informed consent from the patient.
Exclusion Criteria
- Presence of distant metastases
- Patients who are not suitable for curative treatment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint: safety of marker implantation.<br>The review will be performed one week after marker implantation. Any side effects will be recorded.
- Secondary Outcome Measures
Name Time Method